Research output: Contribution to journal › Short survey › peer-review
Freezing of Aqueous Solutions and Chemical Stability of Amorphous Pharmaceuticals : Water Clusters Hypothesis. / Shalaev, Evgenyi; Soper, Alan; Zeitler, J. Axel et al.
In: Journal of Pharmaceutical Sciences, Vol. 108, No. 1, 01.01.2019, p. 36-49.Research output: Contribution to journal › Short survey › peer-review
}
TY - JOUR
T1 - Freezing of Aqueous Solutions and Chemical Stability of Amorphous Pharmaceuticals
T2 - Water Clusters Hypothesis
AU - Shalaev, Evgenyi
AU - Soper, Alan
AU - Zeitler, J. Axel
AU - Ohtake, Satoshi
AU - Roberts, Christopher J.
AU - Pikal, Michael J.
AU - Wu, Ke
AU - Boldyreva, Elena
N1 - Copyright © 2019 Allergan, PLC. Published by Elsevier Inc. All rights reserved.
PY - 2019/1/1
Y1 - 2019/1/1
N2 - Molecular mobility has been traditionally invoked to explain physical and chemical stability of diverse pharmaceutical systems. Although the molecular mobility concept has been credited with creating a scientific basis for stabilization of amorphous pharmaceuticals and biopharmaceuticals, it has become increasingly clear that this approach represents only a partial description of the underlying fundamental principles. An additional mechanism is proposed herein to address 2 key questions: (1) the existence of unfrozen water (i.e., partial or complete freezing inhibition) in aqueous solutions at subzero temperatures and (2) the role of water in the chemical stability of amorphous pharmaceuticals. These apparently distant phenomena are linked via the concept of water clusters. In particular, freezing inhibition is associated with the confinement of water clusters in a solidified matrix of an amorphous solute, with nanoscaled water clusters being observed in aqueous glasses using wide-angle neutron scattering. The chemical instability is suggested to be directly related to the catalysis of proton transfer by water clusters, considering that proton transfer is the key elementary reaction in many chemical processes, including such common reactions as hydrolysis and deamidation.
AB - Molecular mobility has been traditionally invoked to explain physical and chemical stability of diverse pharmaceutical systems. Although the molecular mobility concept has been credited with creating a scientific basis for stabilization of amorphous pharmaceuticals and biopharmaceuticals, it has become increasingly clear that this approach represents only a partial description of the underlying fundamental principles. An additional mechanism is proposed herein to address 2 key questions: (1) the existence of unfrozen water (i.e., partial or complete freezing inhibition) in aqueous solutions at subzero temperatures and (2) the role of water in the chemical stability of amorphous pharmaceuticals. These apparently distant phenomena are linked via the concept of water clusters. In particular, freezing inhibition is associated with the confinement of water clusters in a solidified matrix of an amorphous solute, with nanoscaled water clusters being observed in aqueous glasses using wide-angle neutron scattering. The chemical instability is suggested to be directly related to the catalysis of proton transfer by water clusters, considering that proton transfer is the key elementary reaction in many chemical processes, including such common reactions as hydrolysis and deamidation.
KW - amorphism
KW - chemical stability
KW - deamidation
KW - freeze-drying
KW - lyophilization
KW - protein formulation(s)
KW - solid-state
KW - stability
KW - structure
KW - water sorption
KW - GLASS TRANSITIONS
KW - LYOPHILIZED SOLIDS
KW - LIQUID TRANSITION
KW - PROTEIN-STRUCTURE
KW - MOLECULAR MOBILITY
KW - X-RAY-DIFFRACTION
KW - HYDROGEN/DEUTERIUM EXCHANGE
KW - MONOCLONAL-ANTIBODY
KW - GLUCOSE SOLUTIONS
KW - HYDROGEN-DEUTERIUM EXCHANGE
KW - Temperature
KW - Freezing
KW - Chemical Phenomena
KW - Solutions/chemistry
KW - Freeze Drying/methods
KW - Drug Stability
KW - Water/chemistry
KW - Hydrolysis
KW - Chemistry, Pharmaceutical/methods
UR - http://www.scopus.com/inward/record.url?scp=85054190771&partnerID=8YFLogxK
U2 - 10.1016/j.xphs.2018.07.018
DO - 10.1016/j.xphs.2018.07.018
M3 - Short survey
C2 - 30055227
AN - SCOPUS:85054190771
VL - 108
SP - 36
EP - 49
JO - Journal of Pharmaceutical Sciences
JF - Journal of Pharmaceutical Sciences
SN - 0022-3549
IS - 1
ER -
ID: 16956877